Acasti Pharma Inc Année d'introduction en bourse
Quel est le Année d'introduction en bourse de Acasti Pharma Inc?
Le Année d'introduction en bourse de Acasti Pharma Inc est 2011
Quelle est la définition de Année d'introduction en bourse?
Le premier appel public à l'épargne est un type d'offre publique dans lequel les actions d'une entreprise sont généralement vendues à des investisseurs institutionnels qui, pour leur part, vendent au grand public, pour la première fois, sur une bourse de valeurs.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
Année d'introduction en bourse des entreprises dans Health Care secteur sur NASDAQ par rapport à Acasti Pharma Inc
Que fait Acasti Pharma Inc?
acasti pharma, inc., a subsiduary of neptune technologies & bioressources, is a quebec-based biopharmaceutical dedicated in advancing a proprietary portfolio based on marine phospholipids. our products can be used in prescription, medical food and over-the-counter applications, either as a stand-alone, or, as a fixed-dose combination to exisitng productrs, for the prevention and treatment of cardiometabolic disorders.
Entreprises avec année d'introduction en bourse similaire à Acasti Pharma Inc
- Goldman Sachs Mutual Fund - Goldman Sachs Nifty Exchange Traded Scheme a Année d'introduction en bourse de 2010
- Software Effective Solutions a Année d'introduction en bourse de 2010
- GINSMS a Année d'introduction en bourse de 2010
- Photonike Capital SA a Année d'introduction en bourse de 2010
- Parabolic Drugs a Année d'introduction en bourse de 2010
- West Kirkland Mining a Année d'introduction en bourse de 2010
- Acasti Pharma Inc a Année d'introduction en bourse de 2011
- Omineca Mining and Metals a Année d'introduction en bourse de 2012
- iShares Asia Trust - iShares Core CSI 300 Index ETF a Année d'introduction en bourse de 2012
- Wendy`s Co a Année d'introduction en bourse de 2012
- Unisys a Année d'introduction en bourse de 2012
- Christopher & Banks a Année d'introduction en bourse de 2012
- Wellesley a Année d'introduction en bourse de 2012